Multiple Sclerosis; Targeting of chemokine receptors may be able to control multiple sclerosis
Multiple Sclerosis; Targeting of chemokine receptors may be able to control multiple sclerosis
About this item
Full title
Multiple Sclerosis; Targeting of chemokine receptors may be able to control multiple sclerosis
Publisher
Atlanta: NewsRx
Journal title
Blood Weekly, 2004, p.56
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
"Due to broad pharmacological interest in the chemokine system, peptide antagonists and small molecular antagonists are now available for clinical therapeutic trials. For the treatment of MS in particular, the chemokine receptors CCR1, CCR2, CCR5, and CXCR3 are possible targets in a chemokine-based therapeutic approach. We summarize current knowled...
Alternative Titles
Full title
Multiple Sclerosis; Targeting of chemokine receptors may be able to control multiple sclerosis
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_196501232
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_196501232
Other Identifiers
ISSN
1065-6073
E-ISSN
1532-4559
How to access this item
Log in as a Library member
